Cargando…
Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection
Carbamylated erythropoietin (cEpo), which is neuroprotective but lacks hematopoietic activity, has been attracting rising concerns. However, the cellular and molecular mechanisms involved in the process of neuroprotection of cEpo are not well known. Based on several recent reports, the neuroprotecti...
Autores principales: | Chen, Jianmin, Yang, Zheng, Zhang, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743684/ https://www.ncbi.nlm.nih.gov/pubmed/26862298 http://dx.doi.org/10.4137/BCI.S30753 |
Ejemplares similares
-
Correction to: “Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection”
por: Chen, Jianmin, et al.
Publicado: (2016) -
Effect of Carbamylated Erythropoietin in a Chronic Model of TNBS-Induced Colitis
por: Silva, Inês, et al.
Publicado: (2023) -
Molecular mechanism of the role of carbamyl erythropoietin in treating diabetic retinopathy rats
por: Xu, Xuegu, et al.
Publicado: (2018) -
Comparison of Neurite Outgrowth Induced by Erythropoietin (EPO) and Carbamylated Erythropoietin (CEPO) in Hippocampal Neural Progenitor Cells
por: Oh, Dong Hoon, et al.
Publicado: (2012) -
Spinal Stroke: Outcome Attenuation by Erythropoietin and Carbamylated Erythropoietin and Its Prediction by Sphingosine-1-Phosphate Serum Levels in Mice
por: Koepke, Leon-Gordian, et al.
Publicado: (2022)